Constitutive NFKB pathway activation in multiple myeloma
Constitutive NF-κB pathway activation in multiple myeloma. (A) Genetic abnormalities that activate NF-κB in multiple myeloma. Gray boxes highlight recurrent genetic aberrations in multiple myeloma involving NF-κB pathway components. The kinase NIK is tethered to the ubiquitin ligases c-IAP1 and/c-IAP2 (c-IAP1/2) by TRAF2 and TRAF3, leading to rapid turnover of NIK protein because of c-IAP1/2-catalyzed K46-linked polyubiquitination. On recruitment to a subset of TNF receptor-family proteins—notably CD40, TACI, and lymphotoxin-β receptor (LTBR)—TRAF2 ubiquitin ligase activity is induced, leading to K63-linked polyubiquitination of c-IAP1/2. The K46-linked ubiquitin ligase activity of c-IAP1/2 is directed toward TRAF3, leading to its proteasomal degradation. NIK is liberated and stabilized in the process. NIK overexpression stimulates both the classical and alternative NF-κB pathways. The deubiquitinase CYLD negative regulates this signaling pathway by removing K63-linked polyubiquitin chains from IKKγ. (B) Model of NF-κB activation during the genesis of multiple myeloma. Normal plasma cells receive signals from BAFF and APRIL, two TNF family ligands in the bone marrow microenvironment. Their receptors, TACI and BCMA, are highly expressed in multiple myeloma and signal to NF-κB through both the classical and alternative NF-κB pathways. Initial transformation is often caused by oncogenic translocations, but the myeloma cell may still remain dependent on the bone marrow microenvironment to receive prosurvival NF-κB signals. Myeloma cells that acquire mutations that cause constitutive NF-κB pathway activation are selected because they allow the malignant cells to survive and proliferate without being limited by the bone marrow microenvironment.
Publication
Oncogenic Activation of NF-κB. (2010) Louis M. Staudt. Cold Spring Harb Perspect Biol. 2010 Jun;2(6):a000109. Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | TACI | TACI | ncbigene_synonym | TNFRSF13B | 23495 |
| Homo sapiens | Primates | CD40 | CD40 | ncbigene_symbol | CD40 | 958 |
| Homo sapiens | Primates | *CD40/TACI/LTBR | LTBR | ncbigene_symbol | LTBR | 4055 |
| Homo sapiens | Primates | TRAF2 | TRAF2 | ncbigene_symbol | TRAF2 | 7186 |
| Homo sapiens | Primates | TRAF2 | TRAF2 | ncbigene_synonym | TANK | 10010 |
| Homo sapiens | Primates | *TRAF3/TRAF2 | TRAF3 | ncbigene_symbol | TRAF3 | 7187 |
| Homo sapiens | Primates | c-IAP1 | C-IAP1 | ncbigene_synonym | BIRC2 | 329 |
| Homo sapiens | Primates | c-IAP- | IAP | ncbigene_synonym | ALPI | 248 |
| Homo sapiens | Primates | c-IAP- | IAP | ncbigene_synonym | ALPP | 250 |
| Homo sapiens | Primates | c-IAP- | IAP | ncbigene_synonym | CD47 | 961 |
| Homo sapiens | Primates | c-IAP- | IAP | ncbigene_synonym | IAPP | 3375 |
| Homo sapiens | Primates | c-IAP- | IAP | ncbigene_synonym | MAGT1 | 84061 |
| Homo sapiens | Primates | NIK | NIK | ncbigene_synonym | MAP3K14 | 9020 |
| Homo sapiens | Primates | NIK | NIK | ncbigene_synonym | MAP4K4 | 9448 |
| Homo sapiens | Primates | IKKY | IKKG | ncbigene_synonym | IKBKG | 8517 |
| Homo sapiens | Primates | CYLD | CYLD | ncbigene_symbol | CYLD | 1540 |
| Homo sapiens | Primates | IK | IK | ncbigene_symbol | IK | 3550 |
| Homo sapiens | Primates | IkBa | IKBA | ncbigene_synonym | NFKBIA | 4792 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | CUX1 | 1523 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | NFKB2 | 4791 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | OAS3 | 4940 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | PMEL | 6490 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | SART3 | 9733 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | TPX2 | 22974 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | SND1 | 27044 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | ASCC2 | 84164 |
| Homo sapiens | Primates | p65 | P65 | ncbigene_synonym | RELA | 5970 |
| Homo sapiens | Primates | p65 | P65 | ncbigene_synonym | SYT1 | 6857 |
| Homo sapiens | Primates | p65 | P65 | ncbigene_synonym | GORASP1 | 64689 |
| Homo sapiens | Primates | p65 | P65 | ncbigene_synonym | WNK1 | 65125 |
| Homo sapiens | Primates | p50 | P50 | ncbigene_synonym | ARHGEF7 | 8874 |
| Homo sapiens | Primates | p50 | P50 | ncbigene_synonym | ASCC1 | 51008 |
| Homo sapiens | Primates | p50 | P50 | ncbigene_synonym | H3P40 | 115482723 |
| Homo sapiens | Primates | relB | RELB | ncbigene_symbol | RELB | 5971 |
| Homo sapiens | Primates | p52 | P52 | ncbigene_synonym | FKBP4 | 2288 |
| Homo sapiens | Primates | p52 | P52 | ncbigene_synonym | GTF2H4 | 2968 |
| Homo sapiens | Primates | p52 | P52 | ncbigene_synonym | PMPCB | 9512 |
| Homo sapiens | Primates | p52 | P52 | ncbigene_synonym | PSIP1 | 11168 |
| Homo sapiens | Primates | p52 | P52 | ncbigene_synonym | H3P42 | 115482704 |
| Homo sapiens | Primates | NF-KB | NF-KB | ncbigene_synonym | NFKB1 | 4790 |
| Homo sapiens | Primates | BCMA | BCMA | ncbigene_synonym | TNFRSF17 | 608 |
| Homo sapiens | Primates | APRIL | APRIL | ncbigene_synonym | TNFSF13 | 8741 |
| Homo sapiens | Primates | APRIL | APRIL | ncbigene_synonym | ANP32B | 10541 |
| Homo sapiens | Primates | BAFF | BAFF | ncbigene_synonym | TNFSF13B | 10673 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|